Cite
HARVARD Citation
Wang, D. et al. (2017). Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple‐negative breast cancer. Cancer communications. 36 (1), pp. 1-2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, D. et al. (2017). Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple‐negative breast cancer. Cancer communications. 36 (1), pp. 1-2. [Online].